Canada Markets open in 9 hrs 1 min

Today's Research Reports on CardioComm Solutions, Sernova, Hemostemix and DiaMedica Therapeutics

NEW YORK, NY / ACCESSWIRE / October 25, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

CardioComm Solutions, Inc.
https://rdinvesting.com/news/?ticker=EKG.V

Sernova Corp.
https://rdinvesting.com/news/?ticker=SVA.V

Hemostemix Inc.
https://rdinvesting.com/news/?ticker=HEM.V

DiaMedica Therapeutics Inc.
https://rdinvesting.com/news/?ticker=DMA.V

CardioComm Solutions’ stock had no change Wednesday, to close the day at $0.045. The stock recorded a trading volume of 689,076 shares, which was above its three months average volume of 144,871 shares. In the last year, CardioComm Solutions' shares have traded in a range of 0.04 - 0.08. The share price has gained 12.5% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.05 is lower than its 200-day moving average of $0.05.

Access RDI's CardioComm Solutions, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EKG.V

On Wednesday, shares of Sernova recorded a trading volume of 144,500 shares, which was below the three months average volume of 159,814 shares. The stock ended the day 5.26% higher at $0.20. The share price has fallen 60.78% from its 52 week high with a 52 week trading range of 0.17 - 0.51. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.20 is lower than its 200-day moving average of $0.25. Shares of Sernova have fallen approximately 52.38 percent year-to-date.

Access RDI's Sernova Corp. Research Report at:
https://rdinvesting.com/news/?ticker=SVA.V

Hemostemix’s stock moved 10.53% lower Wednesday, to close the day at $0.085. The stock recorded a trading volume of 62,000 shares, which was below its three months average volume of 235,490 shares. In the last year, Hemostemix's shares have traded in a range of 0.045 - 0.13. The share price has gained 88.89% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.10 is greater than its 200-day moving average of $0.08. Shares of Hemostemix have gained approximately 21.43 percent year-to-date.

Access RDI's Hemostemix Inc. Research Report at:
https://rdinvesting.com/news/?ticker=HEM.V

On Wednesday, shares of DiaMedica Therapeutics recorded a trading volume of 94,600 shares, which was below the three months average volume of 171,780 shares. The stock ended the day 4.08% lower at $0.47. The share price has fallen 47.78% from its 52 week high with a 52 week trading range of 0.21 - 0.90. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.51 is lower than its 200-day moving average of $0.57. Shares of DiaMedica Therapeutics have gained approximately 62.07 percent year-to-date.

Access RDI's DiaMedica Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DMA.V

Our Actionable Research on CardioComm Solutions, Inc. (TSXV:EKG.V), Sernova Corp. (TSXV:SVA.V), Hemostemix Inc. (TSXV:HEM.V) and DiaMedica Therapeutics Inc. (TSXV:DMA.V) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com